-+ 0.00%
-+ 0.00%
-+ 0.00%

NOVO NORDISK'S AWIQLI®, THE FIRST ONCE-WEEKLY BASAL INSULIN FOR ADULTS WITH TYPE 2 DIABETES, NOW AVAILABLE IN THE US

Reuters·08/11/2026 12:00:13

Please log in to view news